DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Ali N, Malik F, Jafri SIM, Naglak M, Sundermeyer M, Pickens PV.
Analysis of efficacy and tolerability of Bruton tyrosine kinase inhibitor ibrutinib in various B-cell malignancies in the general community: a single-center experience.
Clin Lymphoma Myeloma Leuk 2017;
17S: S53-S61
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.